Champions Oncology, Inc. (CSBR)
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. The company provides Lumin Bioinformatics, a software platform and data tool that contains comprehensive information derived from research services and clinical studies, and sold on an annual subscriptions basis. The company markets its products through internet, word of mouth, and sales force to patients and physicians. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
$67.97M
Dr. Ronnie Morris M.D.
230.00
Hackensack, NJ
Nov 30, 1988
-19.23
$-0.26
0.12
0.63
-14.51%
-9.15
-0.73
-35.00
1.33
0.56
-27.84%
1,481.12%
Similar stocks (10)
Eliem Therapeutics, Inc.
ELYM
Rezolute, Inc.
RZLT
Acrivon Therapeutics, Inc. Common Stock
ACRV
Shattuck Labs, Inc.
STTK
Century Therapeutics, Inc.
IPSC
MediciNova, Inc.
MNOV
Aerovate Therapeutics, Inc.
AVTE
Anebulo Pharmaceuticals, Inc.
ANEB
AN2 Therapeutics, Inc.
ANTX
HCW Biologics Inc.
HCWB
ETF Exposure (6)
iShares Micro-Cap ETF
IWC
0.00772%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (10)
Eliem Therapeutics, Inc.
ELYM
Rezolute, Inc.
RZLT
Acrivon Therapeutics, Inc. Common Stock
ACRV
Shattuck Labs, Inc.
STTK
Century Therapeutics, Inc.
IPSC
MediciNova, Inc.
MNOV
Aerovate Therapeutics, Inc.
AVTE
Anebulo Pharmaceuticals, Inc.
ANEB
AN2 Therapeutics, Inc.
ANTX
HCW Biologics Inc.
HCWB
ETF Exposure (6)
iShares Micro-Cap ETF
IWC
0.00772%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%